Copyright © 2002 by the European Society of Cardiology.
Editorials
Enoxaparin in ST elevation MIa bright future
The TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, U.S.A.
References
- Antman EM, Cohen M, Radley D. Assessment of the treatment effect of enoxaparin for unstable Angina/Non-Q-wave myocardial infarction: TIMI 11B-ESSENCE meta-analysis. Circulation. 1999;100:16021608
[Abstract/Free Full Text] - Michalis LK, Papamichail N, Katsouras CS. Enoxaparin versus tinzaparin in the management of unstable coronary artery disease (EVET Study). J Am Coll Cardiol. 2001;37:365A
- Baird SH, Menown IBA, McBride SJ, Trouton TG, Wilson C. Randomized comparison of enoxaparin with unfractionated heparin following fibrinolytic therapy for acute myocardial infarction. Eur Heart J. 2002;23:627632
[Abstract/Free Full Text] - Baird SH, McBride SJ, Trouton TG, Wilson C. Low-molecular-weight heparin versus unfractionated heparin following thrombolysis in myocardial infarction. J Am Coll Cardiol. 1998;31:191A
- Ross AM, Molhoek P, Lundergan C. Randomized comparison of enoxaparin, a low-molecular-weight heparin, with unfractionated heparin adjunctive to recombinant tissue plasminogen activator thrombolysis and aspirin: second trial of Heparin and Aspirin Reperfusion Therapy (HART II). Circulation. 2001;104:648652
[Abstract/Free Full Text] - Frostfeldt G, Ahlberg G, Gustafsson G. Low molecular weight heparin (dalteparin) as adjuvant treatment of thrombolysis in acute myocardial infarctiona pilot study: biochemical markers in acute coronary syndromes (BIOMACS II). J Am Coll Cardiol. 1999;33:627633
[Abstract/Free Full Text] - Lancet. 2001;358:605613[CrossRef][ISI][Medline]
This article has been cited by other articles:
![]() |
S Jadhav, J Petrie, W Ferrell, S Cobbe, and N Sattar Insulin resistance as a contributor to myocardial ischaemia independent of obstructive coronary atheroma: a role for insulin sensitisation? Heart, December 1, 2004; 90(12): 1379 - 1383. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Thorevska, Y. Amoateng-Adjepong, R. Sabahi, I. Schiopescu, A. Salloum, V. Muralidharan, and C. A. Manthous Anticoagulation in Hospitalized Patients With Renal Insufficiency: A Comparison of Bleeding Rates With Unfractionated Heparin vs Enoxaparin Chest, March 1, 2004; 125(3): 856 - 863. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Borja Enoxaparin in unstable coronary artery disease Eur. Heart J., October 2, 2002; 23(20): 1632 - 1632. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


